Position in LH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$805,560
+$89,976 QoQ
Shares Held
2,877
+7.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#496
of 1,040 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ashton Thomas Private Wealth, LLC holds $12,239,667 across 8 Diagnostics & Research names. LH ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
12,543 | $6,288,558 | |
| 2 | DGX |
Quest Diagnostics Inc
|
9,353 | $1,982,368 | |
| 3 | DHR |
Danaher Corp /De/
|
6,669 | $1,270,311 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
2,877 | $805,560 | |
| 5 | A |
Agilent Technologies, Inc.
|
5,221 | $693,505 | |
| 6 | CDNA |
CareDx, Inc.
|
16,502 | $470,307 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,242 | $433,199 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
562 | $295,859 |
All Filings in LH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $805,560 | 2,877 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $715,584 | 2,682 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $606,878 | 2,419 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $610,863 | 2,128 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $390,877 | 1,489 | Shares | Sole | 2025-08-01 | |
| 2024-06-30 | $118,035 | 580 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||